- Home
- SGLY vs SPRC Comparison
SGLY vs SPRC Comparison
Compare SGLY & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGLY | SPRC |
|---|---|---|
| Founded | 2001 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 4.0M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGLY | SPRC |
|---|---|---|
| Price | $0.63 | $1.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 86.3K | ★ 3.5M |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,619,679.00 | $1,306,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 187.98 |
| 52 Week Low | $0.54 | $1.55 |
| 52 Week High | $5.49 | $37.59 |
Technical Indicators
Market Signals| Indicator | SGLY | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 32.97 |
| Support Level | $0.56 | $1.55 |
| Resistance Level | $0.65 | $2.02 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 43.76 | 5.09 |
Price Performance
Historical ComparisonAbout SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.